Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly E Cello

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Investigative Ophthalmology & Visual Science|May 1, 2014
Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)John L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 1, 2015
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E Cello, John L Keltner, Chris A Johnson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 yearsJohn L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Investigative Ophthalmology & Visual Science|March 3, 2016
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)Michael Wall, Chris A Johnson, Kimberly E Cello, et al.
Neuro-Ophthalmology (Aeolus Press)|August 29, 2018
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical TrialsJohn L Keltner, Kimberly E Cello, Laura J Balcer, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment StudyJohn L Keltner, Chris A Johnson, Richard A Levine, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2003
Classification of visual field abnormalities in the ocular hypertension treatment studyJohn L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Glaucoma|December 20, 2007
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS)John L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 21, 2013
Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosisKimberly M Winges, John S Werner, Danielle J Harvey, et al.
Ophthalmology|March 5, 2002
Baseline visual field characteristics in the ocular hypertension treatment studyChris A Johnson, John L Keltner, Kimberly E Cello, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Investigative Ophthalmology & Visual Science|May 1, 2014
Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)John L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 1, 2015
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E Cello, John L Keltner, Chris A Johnson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 yearsJohn L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Investigative Ophthalmology & Visual Science|March 3, 2016
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)Michael Wall, Chris A Johnson, Kimberly E Cello, et al.
Neuro-Ophthalmology (Aeolus Press)|August 29, 2018
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical TrialsJohn L Keltner, Kimberly E Cello, Laura J Balcer, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment StudyJohn L Keltner, Chris A Johnson, Richard A Levine, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2003
Classification of visual field abnormalities in the ocular hypertension treatment studyJohn L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Glaucoma|December 20, 2007
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS)John L Keltner, Chris A Johnson, Kimberly E Cello, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 21, 2013
Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosisKimberly M Winges, John S Werner, Danielle J Harvey, et al.
Ophthalmology|March 5, 2002
Baseline visual field characteristics in the ocular hypertension treatment studyChris A Johnson, John L Keltner, Kimberly E Cello, et al.
Pageof 2